A Review of Approaches to Potentiate the Activity of Temozolomide against Glioblastoma to Overcome Resistance
Article in International Journal of Molecular Sciences (March 2024)
The most recent citing publications are shown below. View all 37 publications that cite this research output on Dimensions.
Phase II Study of Osimertinib in Patients With Epidermal Growth Factor Receptor Mutations: Results From the NCI-MATCH ECOG-ACRIN (EAY131) Trial Subprotocol E.
Article in JCO Precision Oncology (February 2024)
Small Molecule Tyrosine Kinase Inhibitors (TKIs) for Glioblastoma Treatment
Article in International Journal of Molecular Sciences (January 2024)